| Defeating Alzheimer's disease and other dementias: a priority for European science and society B Winblad, P Amouyel, S Andrieu, C Ballard, C Brayne, H Brodaty, ... The Lancet Neurology 15 (5), 455-532, 2016 | 1931 | 2016 |
| DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy KJ Thomas, MK McCoy, J Blackinton, A Beilina, M van der Brug, ... Human molecular genetics 20 (1), 40-50, 2011 | 554 | 2011 |
| Oxidative stress in Alzheimer’s disease: why did antioxidant therapy fail? T Persson, BO Popescu, A Cedazo-Minguez Oxidative medicine and cellular longevity 2014 (1), 427318, 2014 | 408 | 2014 |
| Apolipoprotein E ɛ4 magnifies lifestyle risks for dementia: a population‐based study M Kivipelto, S Rovio, T Ngandu, I Kåreholt, M Eskelinen, B Winblad, ... Journal of cellular and molecular medicine 12 (6b), 2762-2771, 2008 | 381 | 2008 |
| Oxysterols and neurodegenerative diseases I Björkhem, A Cedazo-Minguez, V Leoni, S Meaney Molecular aspects of medicine 30 (3), 171-179, 2009 | 332 | 2009 |
| Involvement of glutaredoxin-1 and thioredoxin-1 in β-amyloid toxicity and Alzheimer's disease S Akterin, RF Cowburn, A Miranda-Vizuete, A Jiménez, N Bogdanovic, ... Cell Death & Differentiation 13 (9), 1454-1465, 2006 | 240 | 2006 |
| Successful therapies for Alzheimer’s disease: why so many in animal models and none in humans? R Franco, A Cedazo-Minguez Frontiers in pharmacology 5, 146, 2014 | 226 | 2014 |
| Pathways to Alzheimer's disease J Hardy, N Bogdanovic, B Winblad, E Portelius, N Andreasen, ... Journal of internal medicine 275 (3), 296-303, 2014 | 219 | 2014 |
| Mitochondrial alterations in PINK1 deficient cells are influenced by calcineurin-dependent dephosphorylation of dynamin-related protein 1 A Sandebring, KJ Thomas, A Beilina, M van der Brug, MM Cleland, ... PloS one 4 (5), e5701, 2009 | 216 | 2009 |
| Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities A Cedazo‐Mínguez Journal of cellular and molecular medicine 11 (6), 1227-1238, 2007 | 212 | 2007 |
| Biomarkers for Alzheimer’s disease and other forms of dementia: clinical needs, limitations and future aspects A Cedazo-Minguez, B Winblad Experimental gerontology 45 (1), 5-14, 2010 | 206 | 2010 |
| Toward a predictive model of Alzheimer’s disease progression using capillary electrophoresis–mass spectrometry metabolomics C Ibáñez, C Simo, PJ Martin-Alvarez, M Kivipelto, B Winblad, ... Analytical chemistry 84 (20), 8532-8540, 2012 | 199 | 2012 |
| Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia E Bereczki, PT Francis, D Howlett, JB Pereira, K Höglund, A Bogstedt, ... Alzheimer's & Dementia 12 (11), 1149-1158, 2016 | 177 | 2016 |
| Apolipoprotein E: a major piece in the Alzheimer's disease puzzle A Cedazo‐Minguez, RF Cowburn Journal of cellular and molecular medicine 5 (3), 254-266, 2001 | 150 | 2001 |
| Apolipoprotein E and β‐amyloid (1–42) regulation of glycogen synthase kinase‐3β A Cedazo‐Minguez, BO Popescu, JM Blanco‐Millan, S Akterin, JJ Pei, ... Journal of neurochemistry 87 (5), 1152-1164, 2003 | 146 | 2003 |
| Current and emerging avenues for Alzheimer's disease drug targets R Loera‐Valencia, A Cedazo‐Minguez, PA Kenigsberg, G Page, ... Journal of internal medicine 286 (4), 398-437, 2019 | 144 | 2019 |
| Can LDL cholesterol be too low? Possible risks of extremely low levels AG Olsson, B Angelin, G Assmann, CJ Binder, I Björkhem, ... Journal of internal medicine 281 (6), 534-553, 2017 | 119 | 2017 |
| Decreased levels of guanosine 3′, 5′‐monophosphate (c GMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in A lzheimer's disease A Ugarte, F Gil‐Bea, C García‐Barroso, Á Cedazo‐Minguez, MJ Ramírez, ... Neuropathology and applied neurobiology 41 (4), 471-482, 2015 | 117 | 2015 |
| A new metabolomic workflow for early detection of Alzheimer's disease C Ibáñez, C Simó, DK Barupal, O Fiehn, M Kivipelto, A Cedazo-Mínguez, ... Journal of Chromatography A 1302, 65-71, 2013 | 115 | 2013 |
| Vitamin D in relation to cognitive impairment, cerebrospinal fluid biomarkers, and brain volumes B Hooshmand, J Lökk, A Solomon, F Mangialasche, J Miralbell, ... Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2014 | 109 | 2014 |